| Fiscal Q4 Ending 12/12 |
Fiscal Q3 Ending 09/12 |
Fiscal Q2 Ending 06/12 |
Fiscal Q1 Ending 03/12 |
Fiscal Q4 Ending 12/11 |
|
Sales/Revenue |
7,889,000 | 7,911,000 | 8,107,000 | 7,437,000 | 7,679,000 |
Cost of Goods Sold (COGS) incl. D&A |
2,705,000 | 2,608,000 | 2,687,000 | 2,451,000 | 2,746,000 |
COGS excluding D&A |
2,472,000 | 2,392,000 | 2,465,000 | 2,224,000 | 2,496,000 |
Depreciation & Amortization Expense |
233,000 | 216,000 | 222,000 | 227,000 | 250,000 |
Gross Income |
5,184,000 | 5,303,000 | 5,420,000 | 4,986,000 | 4,933,000 |
SG&A Expense |
1,935,000 | 1,655,000 | 1,817,000 | 1,571,000 | 1,945,000 |
Research & Development |
NA | 0 | 0 | 0 | 413,000 |
Other SG&A |
1,935,000 | 1,655,000 | 1,817,000 | 1,571,000 | 1,532,000 |
Other Operating Expense |
0 | 0 | 0 | 0 | 0 |
Unusual Expense |
33,000 | 33,000 | 9,000 | 26,000 | 20,000 |
Non Operating Income/Expense |
0 | 0 | 0 | 0 | 110,000 |
Equity in Affiliates (Pretax) |
NA | 0 | NA | 0 | 0 |
Interest Expense |
226,000 | 203,000 | 199,000 | 199,000 | 329,000 |
Gross Interest Expense |
226,000 | 203,000 | 199,000 | 199,000 | 329,000 |
Pretax Income |
2,990,000 | 3,412,000 | 3,395,000 | 3,190,000 | 2,749,000 |
Income Tax |
799,000 | 1,088,000 | 988,000 | 958,000 | 803,000 |
Equity in Affiliates |
0 | 0 | 0 | 0 | 0 |
Consolidated Net Income |
2,191,000 | 2,312,000 | 2,395,000 | 2,220,000 | 1,935,000 |
Minority Interest Expense |
96,000 | 97,000 | 90,000 | 71,000 | 60,000 |
Net Income |
2,095,000 | 2,215,000 | 2,305,000 | 2,149,000 | 1,875,000 |
Extraordinaries & Discontinued Operations |
0 | 0 | 0 | 0 | 0 |
Extra Items & Gain/Loss Sale Of Assets |
0 | 0 | 0 | 0 | 0 |
Cumulative Effect - Accounting Chg |
0 | 0 | 0 | 0 | 0 |
Discontinued Operations |
0 | 0 | 0 | 0 | 0 |
Net Income After Extraordinaries |
2,095,000 | 2,215,000 | 2,304,999 | 2,148,999 | 1,875,000 |
Preferred Dividends |
0 | 0 | 0 | 0 | 0 |
Net Income available to Common |
2,095,000 | 2,215,000 | 2,305,000 | 2,149,000 | 1,875,000 |
Operational EPS |
1.26 | 1.33 | 1.36 | 1.26 | 1.07 |
EPS (basic) |
1.25 | 1.32 | 1.36 | 1.25 | 1.06 |
EBITDA |
3,482,000 | 3,864,000 | 3,825,000 | 3,642,000 | 3,238,000 |
Depreciation & Amortization Expense |
233,000 | 216,000 | 222,000 | 227,000 | 250,000 |
Common Shares Outstanding |
NA | 1,683,000 | 1,701,000 | 1,719,000 | 1,762,000 |
Basic Shares Outstanding |
1,676,000 | 1,683,000 | 1,701,000 | 1,719,000 | 1,761,000 |
Diluted Shares Outstanding |
1,676,000 | 1,683,000 | 1,701,000 | 1,719,000 | 1,762,000 |
Diluted EPS after Extraordinary Items |
1.25 | 1.32 | 1.36 | 1.25 | 1.06 |
Discont. Operations Per Share |
NA | 0 | 0 | 0 | 0 |
Continued operations EPS |
NA | 1.32 | 1.36 | 1.25 | 1.06 |
*Figures in thousands of U.S. Dollars except shares outstanding.
